Search Results - "Roblot, F."

Comment on ‘Cutaneous manifestations in COVID‐19: a first perspective’ by Recalcati S by Hedou, M., Carsuzaa, F., Chary, E., Hainaut, E., Cazenave‐Roblot, F., Masson Regnault, M.

“…Since the coronavirus disease 2019 (COVID 19) outbreak was first reported in the Chinese city of Wuhan on December 31, 2019, it has stricken more than…”
Get full text

High impact of COVID-19 outbreak in a nursing home in the Nouvelle-Aquitaine region, France, March to April 2020 by Bernadou, A, Bouges, S, Catroux, M, Rigaux, J C, Laland, C, Levêque, N, Noury, U, Larrieu, S, Acef, S, Habold, D, Cazenave-Roblot, F, Filleul, L

“…Elderly people in nursing homes are particularly vulnerable to COVID-19 due to their age, the presence of comorbidities, and community living. On March 14,…”
Get full text

Ensuring universal access to old antibiotics: a critical but neglected priority by Pulcini, C., Beovic, B., Béraud, G., Carlet, J., Cars, O., Howard, P., Levy-Hara, G., Li, G., Nathwani, D., Roblot, F., Sharland, M.

Get full text

Osteoarticular manifestations of Q fever: a case series and literature review by Meriglier, E., Sunder, A., Elsendoorn, A., Canoui, E., Rammaert, B., Million, M., Raoult, D., Roblot, F.

Get full text

Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia? by Joncour, A., Puyade, M., Michaud, A., Tourani, J-M., Cazenave-Roblot, F., Rammaert, Blandine

“…Introduction Fever of unknown origin is by far the most common diagnosis in low-risk febrile neutropenic patients undergoing chemotherapy. The current…”
Get full text

A case of Q fever with erythema nodosum by Meriglier, E., Asquier, L., Roblot, F., Roblot, P., Landron, C.

“…Background Acute Q fever is asymptomatic in 60% of the patients, while the reminder may present with fever, pneumoniae, and hepatitis. Skin manifestations are…”
Get full text

Feasibility of early switch to oral antibiotic in brain abscesses and empyema: a multicentre retrospective study by Lauda-Maillen, M., Lemaignen, A., Puyade, M., Catroux, M., Le Moal, G., Beraud, G., El Hajj, H., Michaud, A., Destrieux, C., Bernard, L., Rammaert, B., Cazenave-Roblot, F.

Get full text

Optimal Duration of Antibiotic Therapy in Vertebral Osteomyelitis by Roblot, F., MD, Besnier, J.M., MD, Juhel, L., MD, Vidal, C., MD, Ragot, S., PhD, Bastides, F., MD, Le Moal, G., MD, Godet, C., MD, Mulleman, D., MD, Azaïs, I., MD, Becq-Giraudon, B., MD, Choutet, P., MD

“…Objectives To compare the risk of relapse of vertebral osteomyelitis (VO), according to the duration of antibiotic therapy (≤6 weeks versus >6 weeks). Methods…”
Get full text

Microbiological diagnosis of vertebral osteomyelitis: relevance of second percutaneous biopsy following initial negative biopsy and limited yield of post-biopsy blood cultures by Gras, G., Buzele, R., Parienti, J. J., Debiais, F., Dinh, A., Dupon, M., Roblot, F., Mulleman, D., Marcelli, C., Michon, J., Bernard, L.

“…The purpose of this investigation was to evaluate the microbiological diagnosis yield of post-biopsy blood cultures (PBBCs) and second percutaneous needle…”
Get full text

Long-term infectious risks after splenectomy: A retrospective cohort study with up to 10 years follow-up by Meriglier, E, Puyade, M, Carretier, M, Roblot, F, Roblot, P

“…Although most infections occur within the first 2 years after splenectomy, the relatively short follow-up reported in many studies may underestimate the…”
Get full text

Antiparasitic activities of medicinal plants used in Ivory Coast by Okpekon, T, Yolou, S, Gleye, C, Roblot, F, Loiseau, P, Bories, C, Grellier, P, Frappier, F, Laurens, A, Hocquemiller, R

“…During an ethnopharmacological survey of antiparasitic medicinal plants used in Ivory Coast, 17 plants were identified and collected. Polar, non-polar and…”
Get full text

Temocillin and urinary tract infections by Vallée, M, Bruyère, F, Roblot, F, Brureau, L

“…Temocillin is an alternative to treat urinary tract infections with bacteria producing extended spectrum beta-lactamase (ESBL). The objective is to evaluate…”
Get more information

Public health issues and health rendezvous for migrants from conflict zones in Ukraine: A French practice guideline by Vignier, N., Halley des Fontaines, V., Billette de Villemeur, A., Cazenave-Roblot, F., Hoen, B., Chauvin, F., Lepelletier, D., Chidiac, C., Billaud, E.

“…•Migrants fleeing Ukraine may be affected or exposed to infectious diseases, mental health disorders and chronic diseases.•First, initial health and social…”
Get full text

Vaccination coverage in French 17-year-old young adults: an assessment of mandatory and recommended vaccination statuses by ROBLOT, F., ROBIN, S., CHUBILLEAU, C., GIRAUD, J., BOUFFARD, B., INGRAND, P.

“…We aimed to assess vaccination coverage (VC) in 17-year-old French young adults (YAs) participating in one mandatory Day of Defence and Citizenship (DDC)…”
Get full text

Pneumocystosis in non-HIV-infected immunocompromised patients by Fillâtre, P, Revest, M, Belaz, S, Robert-Gangneux, F, Zahar, J-R, Roblot, F, Tattevin, P

“…Pneumocystis jiroveci (formerly P. carinii) is an opportunistic fungus responsible for pneumonia in immunocompromised patients. Pneumocystosis in…”
Get full text

Uncommon cutaneous presentation of visceral Leishmaniasis associated with HIV by Cossart, C, Le Moal, G, Garcia, M, Frouin, E, Hainaut-Wierzbicka, E, Roblot, F

“…Visceral leishmaniasis is not normally expressed in skin. Herein, we describe the case of an HIV-positive patient who developed two unusual skin manifestations…”
Get full text

Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients by ROBLOT, F, GODET, C, ROBLOT, P, BECQ-GIRAUDON, B, LE MOAL, G, GARO, B, FAOUZI SOUALA, M, DARY, M, DE GENTILE, L, GANDJI, J. A, GUIMARD, Y, LACROIX, C

“…The aim of this retrospective study was to determine the underlying diseases associated with Pneumocystis carinii pneumonia (PCP) in immunocompromised…”
Get full text

Benefit of CT scanning for assessing pulmonary disease in the immunodepressed patient by Godet, C, Elsendoorn, A, Roblot, F

“…Abstract Introduction Management of pulmonary disease in immunodepressed patients requires a clear diagnostic and therapeutic strategy and multidisciplinary…”
Get full text

Candida endocarditis: role of new antifungal agents by Talarmin, J.P, Boutoille, D, Tattevin, P, Abgueguen, P, Ansart, S, Roblot, F, Raffi, F

“…Despite the relative high frequency of Candida bloodstream infection, Candida endocarditis is a rare entity. We report seven cases, which occurred during a…”
Get full text

Évaluation du suivi des recommandations françaises sur la prise en charge des dermohypodermites bactériennes non nécrosantes au CHU de Poitiers : enquête sur l’évolution des pratiques en trois ans by Bessière, L., Boutin, D., Barbarin, C., Roblot, F. Cazenave, Mimoz, O., Hainaut, E., Regnault, M. Masson

“…Objectifs : La Haute Autorité de santé a publié en 2019 des recommandations concernant la prise en charge des dermohypodermites bactériennes non nécrosantes…”
Get full text